Floatz logo

Indocyanine Green

Resectable Colorectal Carcinoma

Leiden University Medical CenterSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Resectable Colorectal Carcinoma cohort.

Asset / SponsorPhaseRating
Amivantamab-Vmjw
Gruppo Oncologico del Nord-Ovest
Phase 2CCC
Darizmetinib
Mayo Clinic
Phase 2CCC
Vorbipiprant
Gruppo Oncologico del Nord-Ovest
Phase 2CCC
SOLUBLE FLUORESCEIN
Mayo Clinic
N/AD

Same molecule, other indications

Indocyanine Green is also rated in:

cervical cancerDormant
BB
Indicative ·
70 / 100
View asset →
endometrial carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
vulva cancerDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →